- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Solid Tumor in New Zealand
Total 3855 results
-
Treadwell Therapeutics, IncTIO Discovery EngineRecruitingAdvanced Solid MalignanciesUnited States, Hong Kong, Canada
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid MalignanciesUnited States, Spain
-
DualityBio Inc.RecruitingAdvanced Solid TumorsUnited States, Australia
-
Nina BhardwajCompletedSolid TumorsUnited States
-
GenmabBioNTech SEActive, not recruitingSolid Tumor, AdultSpain, United States
-
Novartis PharmaceuticalsActive, not recruiting
-
New Mexico Cancer Care AllianceChristus Stehlin Foundation for Cancer ResearchCompletedAdvanced Solid Tumors | LymphomasUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedSolid TumorsUnited States
-
R-PharmNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Yale UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Helsinn Healthcare SALabcorp Drug Development IncWithdrawnAdvanced Solid Tumor | CNS Tumor | Recurrent WHO Grade II GliomaUnited States, Canada, Germany
-
Debiopharm International SACompletedSolid TumorUnited States, Spain, France
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCActive, not recruitingMetastatic Cancer | Advanced Cancer | Solid TumorsUnited States
-
Indaptus Therapeutics, IncTranslational Drug DevelopmentRecruiting
-
Jacobio Pharmaceuticals Co., Ltd.AbbVieRecruitingNSCLC | Solid TumorUnited States
-
Effector TherapeuticsRecruitingSolid Tumor, AdultUnited States
-
Merck Sharp & Dohme LLCAstraZenecaRecruitingAdvanced Solid NeoplasmsUnited States, Argentina, Australia, Canada, Colombia, Denmark, France, Guatemala, Ireland, Israel, Japan, Korea, Republic of, Mexico, Peru, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom, Italy
-
Achilles Therapeutics UK LimitedRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingSolid TumorsAustralia
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
New York Medical CollegeTerminatedSarcoma | Neuroblastoma | Wilms' Tumor | Refractory Solid Tumor | Recurrent Solid TumorUnited States
-
Roswell Park Cancer InstituteNovartisCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Roswell Park Cancer InstituteCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Roswell Park Cancer InstituteCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Vion PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
SanofiRecruitingSolid TumorUnited States, Israel, Netherlands, Spain
-
Infinity Pharmaceuticals, Inc.CompletedSolid TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; University of PittsburghCompletedSolid TumorsUnited States
-
Genzyme, a Sanofi CompanyCompletedSolid TumorsUnited States
-
Georgetown UniversityOregon Health and Science University; Tesaro, Inc.TerminatedHomologous Recombination Deficiency | Solid Tumor, AdultUnited States
-
ABM Therapeutics CorporationActive, not recruitingAdvanced Solid Tumor | BRAF V600 MutationUnited States
-
Roswell Park Cancer InstituteCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States